pirinixic acid has been researched along with Cardiac Hypertrophy in 2 studies
pirinixic acid: structure
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pellieux, C | 1 |
| Montessuit, C | 1 |
| Papageorgiou, I | 1 |
| Lerch, R | 1 |
| Young, ME | 1 |
| Laws, FA | 1 |
| Goodwin, GW | 1 |
| Taegtmeyer, H | 1 |
2 other studies available for pirinixic acid and Cardiac Hypertrophy
| Article | Year |
|---|---|
Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.
Topics: Acyl-CoA Dehydrogenase; Animals; Atrial Natriuretic Factor; Cardiomegaly; Carnitine O-Palmitoyltrans | 2007 |
Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart.
Topics: Actins; Animals; Aorta; Atrial Natriuretic Factor; Cardiomegaly; Down-Regulation; Glucose; Isoenzyme | 2001 |